Safety of BNT162b2 mRNA COVID-19 vaccine batches: A nationwide cohort study
View ORCID ProfileAnders Hviid, Ingrid Bech Svalgaard
doi: https://doi.org/10.1101/2024.01.22.24301520
Anders Hviid
1Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
2Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
DrMedSciIngrid Bech Svalgaard
1Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
MScArticle usage
Posted January 24, 2024.
Safety of BNT162b2 mRNA COVID-19 vaccine batches: A nationwide cohort study
Anders Hviid, Ingrid Bech Svalgaard
medRxiv 2024.01.22.24301520; doi: https://doi.org/10.1101/2024.01.22.24301520
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12607)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4479)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1058)
- Hematology (378)
- HIV/AIDS (908)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4240)
- Nursing (227)
- Nutrition (620)
- Oncology (2222)
- Ophthalmology (631)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (486)
- Public and Global Health (6825)
- Radiology and Imaging (1502)
- Respiratory Medicine (908)
- Rheumatology (430)
- Sports Medicine (374)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)